Evidence map›Paper›PMID 16155125›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1.

Gunhild Unterstab, Stephan Ludwig, Aline Anton, Oliver Planz, Bianca Dauber, Daniel Krappmann, Gudrun Heins, Christina Ehrhardt, Thorsten Wolff

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genetic trends in parrot Bornavirus: a clinical analysis.The Journal of veterinary medical science · 2024
    Article
  5. ZebrafishJournal of virology · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Targeting TANK-binding kinase 1 (TBK1) in cancer.Expert opinion on therapeutic targets · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Hippocampal expression of a virus-derived protein impairs memory in mice.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gunhild UnterstabRobert Koch Institute, FG12, Nordufer 20, 13353 Berlin, Germany.
Stephan Ludwig
Aline Anton
Oliver Planz
Bianca Dauber
Daniel Krappmann
Gudrun Heins
Christina Ehrhardt
Thorsten Wolff
Friedrich-Loeffler-Institut · DEMax Delbrück Center · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of the antiviral cytokines IFN-alpha/beta is among the most potent innate defenses of higher vertebrates to virus infections, which is controlled by the inducible transcription factor IFN regulatory factor (IRF)3. Borna disease virus (BDV) establishes persistent noncytolytic infections in animals and tissue culture cells, indicating that it can circumvent this antiviral reaction by an unexplained activity. In this study, we identify the BDV P protein as microbial gene product that associates with and inhibits the principal regulatory kinase of IRF3, Traf family member-associated NF-kappaB activator (TANK)-binding kinase 1 (TBK-1). We demonstrate that the P protein counteracts TBK-1-dependent IFN-beta expression in cells and, hence, the establishment of an antiviral state. Furthermore, our data show that the BDV P protein itself is phosphorylated by TBK-1, suggesting that P functions as a viral decoy substrate that prevents activation of cellular target proteins of TBK-1. Thus, our findings provide evidence for a previously undescribed mechanism by which a viral protein interferes with the induction of the antiviral IFN cascade.

Indexed as

AnimalsBorna DiseaseBorna disease virusCell LineDNA-Binding ProteinsDogsHumansInterferon-alphaInterferon-betaInterferon Regulatory Factor-3PhosphoproteinsPhosphorylationProtein Serine-Threonine KinasesTranscription FactorsTumor Necrosis Factor Receptor-Associated Peptides and ProteinsViral ProteinsDNA-Binding ProteinsInterferon-alphaInterferon-betaInterferon Regulatory Factor-3IRF3 protein, humanPhosphoproteinsP protein, Borna disease virusProtein Serine-Threonine KinasesTBK1 protein, humanTranscription FactorsTumor Necrosis Factor Receptor-Associated Peptides and ProteinsViral ProteinsViral Structural Proteins

Identifiers

PMID16155125
PMCPMC1224622
OpenAlexW2059919038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.